Sublingual Semaglutide and Tirzepatide are now available! Get Started
Dashboard
Formulas

Dimercaptosuccinic Acid 150 mg Slow Release Capsules

Dimercaptosuccinic Acid (DMSA) 150 mg Slow Release Capsules, formulated with Methocel E4M, are designed to gradually release the active ingredient over an extended period. This controlled-release mechanism offers sustained therapeutic effects, reduces dosing frequency, and improves patient compliance. These capsules are used to treat conditions such as Wilson's Disease, Lead Poisoning, Mercury Poisoning, Arsenic Poisoning, and Cadmium Poisoning.

Want a different strength?
Click the Text Us button below.
To prescribe, you must be a verified prescriber.
To prescribe, you must be in a state where we hold an active out-of-state pharmacy license.
Starting at
Must be E-Prescribed
Get Started
Generate LeafletShow Leaflet
This medication requires a prescription from your doctor
Are you a prescriber? Sign Up
Trusted by 60,357 patients to date.
A group of faces of our past satisfied patients.
A svg symbol of a mortar and pestle with ingredients going in.
Custom made in our compounding labs.
Sliders that show the customization of ingredients.
Personalized treatment for better results.
User with a gear showing the personalization of the formulation.
All strengths and ingredients are tailored to your needs.
This medication is not available at retail pharmacies. It is compounded, and may be more effective at treating you or your patient.
Slow Release Capsules
6427079ea64324793f5189e7
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Loading icon rotating.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Dosing Calculator

Get general dosing information for a patient by using this calculator.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Loading icon rotating.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Formula Information

A small arrow pointing down

Dimercaptosuccinic Acid (DMSA) 150 mg Slow Release Capsules are a specialized compounded formulation designed to provide a controlled and prolonged release of the active ingredient. This prescription medication is primarily used in the treatment of heavy metal poisoning, lead poisoning, Wilson's Disease, and certain types of kidney disease. DMSA is a potent chelating agent that binds to heavy metals within the body, facilitating their excretion via urine.

The capsules are formulated with Methocel E4M, a type of controlled-release polymer. This innovative formulation ensures the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism also reduces the dosing frequency, thereby improving patient compliance, particularly for medications requiring a controlled and prolonged release profile.

DMSA 150 mg Slow Release Capsules are administered orally, typically once daily. The capsules should be swallowed whole, accompanied by a full glass of water. Adherence to the prescribed medication regimen is crucial, and doses should not be skipped.

Patients taking DMSA 150 mg Slow Release Capsules may experience side effects such as nausea, vomiting, diarrhea, and abdominal pain. It is essential to promptly contact your healthcare provider if any of these side effects occur.

Healthcare providers should note that DMSA 150 mg Slow Release Capsules may interact with other medications, including antacids, antibiotics, and anticonvulsants. Therefore, a comprehensive review of a patient's medication list is necessary prior to prescribing DMSA 150 mg Slow Release Capsules.

If you have any questions or require further information about DMSA 150 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. Our team of compounding pharmacists is equipped with the knowledge and expertise to assist you.

Drug Interactions

A small arrow pointing down

Dimercaptosuccinic Acid 150 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.

These capsules may interact with other medications, supplements, or herbal products. It is crucial for patients to inform their healthcare provider of all medications, supplements, and herbal products they are currently taking before starting this medication. Additionally, patients should disclose any allergies or medical conditions that may affect the metabolism of this medication.

Dimercaptosuccinic Acid 150 mg Slow Release Capsules may also interact with certain foods, such as dairy products. Patients are advised to avoid consuming these foods while taking this medication.

This medication is used to treat various disease states, including lead poisoning, Wilson's disease, and cystinuria. It is important to note that it may interact with other medications used to treat these conditions, such as penicillamine, potentially increasing the risk of side effects. Therefore, patients should inform their healthcare provider of all medications they are taking before starting this medication.

Furthermore, Dimercaptosuccinic Acid 150 mg Slow Release Capsules may interact with certain laboratory tests, such as urine tests for lead, potentially interfering with the results. Patients should inform their healthcare provider of any laboratory tests they are undergoing before starting this medication.

If you have any questions about the interactions of Dimercaptosuccinic Acid 150 mg Slow Release Capsules, please consult with your healthcare provider.

How Does it Work

A small arrow pointing down

Dimercaptosuccinic Acid 150 mg Slow Release Capsules are a specialized formulation designed to treat a range of conditions such as lead poisoning, Wilson's disease, and cystinuria. The active ingredient in these capsules is dimercaptosuccinic acid, a potent chelating agent that has the ability to bind to heavy metals and other toxins present in the body, facilitating their excretion through urine.

What sets these capsules apart is their slow-release formulation. They are designed with Methocel E4M, a type of controlled-release polymer. This innovative design allows for the gradual release of the encapsulated medication over an extended period of time. This slow release ensures a sustained therapeutic effect, providing a more consistent level of medication in the body. This can lead to improved patient compliance, especially for those requiring a controlled and prolonged release profile for their medication.

When taking Dimercaptosuccinic Acid 150 mg Slow Release Capsules, it is crucial to follow the prescribed dosage from your healthcare provider. The capsules should be consumed with food and a sufficient amount of water to aid in proper absorption. Additionally, maintaining a high fluid intake throughout the day is recommended to assist in flushing out the toxins that have been bound by the medication.

If you have any queries or concerns regarding Dimercaptosuccinic Acid 150 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. Our team is committed to helping you understand the workings of this medication and how it can assist in managing your specific disease state.

Other Uses

A small arrow pointing down

Dimercaptosuccinic Acid 150 mg Slow Release Capsules are a versatile treatment option for a variety of conditions. These capsules are particularly effective in treating heavy metal poisoning, including exposure to copper, iron, and zinc. They are also beneficial in managing certain genetic disorders such as cystinuria and cystinosis, which are characterized by the abnormal transport of certain amino acids.

These capsules can also be used in the treatment of specific types of kidney stones, particularly cystine stones. Cystine stones are a common complication of cystinuria, and the slow release of Dimercaptosuccinic Acid can help manage this condition effectively.

Furthermore, Dimercaptosuccinic Acid 150 mg Slow Release Capsules can be used to treat certain types of anemia, such as sideroblastic anemia. This condition is characterized by the body's inability to incorporate iron into hemoglobin, and the slow release of this medication can help manage the symptoms.

These capsules can also be beneficial in treating certain types of liver disease, such as primary biliary cirrhosis. This is a chronic disease that slowly destroys the bile ducts in the liver, and the slow release of Dimercaptosuccinic Acid can help manage this condition.

Additionally, Dimercaptosuccinic Acid 150 mg Slow Release Capsules can be used to treat certain types of kidney disease, such as Fanconi syndrome. This is a rare disorder that affects the kidney's ability to absorb certain substances, and the slow release of this medication can help manage the symptoms.

Finally, these capsules can also be used to treat certain types of skin disorders, such as erythema nodosum. This is a skin condition that causes red, painful lumps to form beneath the skin, and the slow release of Dimercaptosuccinic Acid can help manage this condition.

If you have any questions about the use of Dimercaptosuccinic Acid 150 mg Slow Release Capsules for any of these conditions, please reach out for further information.

Frequently Asked Questions

A small arrow pointing down

What is the main ingredient in these capsules?

The main ingredient in these capsules is Dimercaptosuccinic Acid, which is present in a concentration of 150 mg.

What is the purpose of Methocel E4M in the formulation?

Methocel E4M is a type of controlled-release polymer. It is designed to release the encapsulated medication or active ingredient gradually over an extended period of time. This offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.

What does 'slow release' mean?

'Slow release' refers to the gradual release of the medication over an extended period of time. This is achieved through the use of a controlled-release polymer, Methocel E4M, in the formulation of the capsules.

How often do I need to take these capsules?

Due to the slow-release nature of these capsules, the dosing frequency is reduced. However, the exact frequency will depend on your doctor's prescription and your specific medical condition.

What are the benefits of slow-release capsules?

Slow-release capsules offer several benefits. They provide sustained therapeutic effects, reduce the need for frequent dosing, and improve patient compliance, especially for medications that require a controlled and prolonged release profile.

Are these capsules safe to use?

Yes, these capsules are safe to use as prescribed by your doctor. However, like all medications, they may have side effects. If you experience any adverse reactions, contact your healthcare provider immediately.

Can I break or crush these capsules?

No, these capsules should not be broken or crushed. Doing so can interfere with the controlled-release mechanism and may lead to a sudden release of the medication, which can have harmful effects.

What should I do if I miss a dose?

If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double the dose to catch up.

Can I take these capsules with food?

These capsules can be taken with or without food. However, it is important to take them as directed by your healthcare provider.

What should I do in case of an overdose?

If you suspect an overdose, seek immediate medical attention. Symptoms of an overdose may vary depending on several factors, including the amount of medication taken and individual health conditions.

Related Formulas

Related Products
Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.
NEW PRESCRIPTION ORDER FORM
1
Circle for steps.
Patient Information
2
Circle for steps.
Prescriber and Prescription Information
3
Circle for steps.
Fax order form to Bayview Pharmacy at 401-284-4506.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.